biologics - usp€¦ · and skills in dossier assessment and registration of biologics, so that...

1
GHIP041F_2017-02 About CePAT The U.S. Pharmacopeial Convention’s Center for Pharmaceutical Advancement and Training (USP–Ghana [CePAT])in Accra, Ghana, was established to help build human resource capacity in pharmaceutical quality assurance and quality control by training local professionals to serve as technical experts. CePAT delivers an integrated platform of training, testing and consulting services to support a sustainable approach to medicines quality assurance. USP–Ghana (CePAT) is included under USP’s ISO 9001:2008 certification and its QC testing laboratory has earned accreditation to ISO/IEC 17025:2005. Course Overview Regulation of biologics is a new and challenging area of medicines regulation on the African continent. National regulatory frameworks supporting this vary greatly among countries, as does the degree of technical capacity of personnel to carry out dossier evaluations that adequately assess the safety, quality and efficacy of biologicals. CePAT offers a practical training that includes the analysis of real dossiers, to help build the necessary knowledge and skills in dossier assessment and registration of biologics, so that participants can apply that knowledge to their countries’ regulatory frameworks. Who Should Attend National regulators, biologics manufacturers and procurement agents involved in biologics quality assessments; professionals involved in dossier assessments with a focus on biologics; consultants and individuals interested in the regulatory procedures to assess the safety, efficacy and quality of biologics Learning Objectives Understand the principles of biologics regulation to ensure the safety, efficacy and quality of biologics Understand the details of manufacturing validation, with particular emphasis on vaccines, biologicals and sterile products Understand the components of regulatory safety, quality and efficacy approvals—from both clinical and quality perspectives Course Topics Good clinical practices Clinical trials Aseptic sterilization Manufacturing, GMP, validation, stability and specifications for biologics A biologic product manufactured in a prokaryotic cell (E. coli, Insulin) A biologic manufactured in a mammalian cell line (Erythropoeitin) Evaluation of a monoclonal antibody (Mabs) Manufacturing, GMP, validation, stability and specifications for vaccines For more information, please visit usp.org/ghana. Biologics Next CePAT Course To apply and be considered a candidate, contact [email protected] or visit usp.org/cepat. Fees may apply. A welcome dinner will be provided. Group photos will be taken during the course. Duration: Location: Format: Date:

Upload: others

Post on 21-Sep-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Biologics - USP€¦ · and skills in dossier assessment and registration of biologics, so that participants can apply that knowledge to their countries’ regulatory frameworks

GHIP041F_2017-02

About CePAT

The U.S. Pharmacopeial Convention’s Center for Pharmaceutical

Advancement and Training (USP–Ghana [CePAT])in Accra,

Ghana, was established to help build human resource capacity

in pharmaceutical quality assurance and quality control by

training local professionals to serve as technical experts. CePAT

delivers an integrated platform of training, testing and consulting

services to support a sustainable approach to medicines quality

assurance. USP–Ghana (CePAT) is included under USP’s ISO

9001:2008 certification and its QC testing laboratory has earned

accreditation to ISO/IEC 17025:2005.

Course Overview

Regulation of biologics is a new and challenging area of

medicines regulation on the African continent. National regulatory

frameworks supporting this vary greatly among countries, as does

the degree of technical capacity of personnel to carry out dossier

evaluations that adequately assess the safety, quality and efficacy

of biologicals. CePAT offers a practical training that includes the

analysis of real dossiers, to help build the necessary knowledge

and skills in dossier assessment and registration of biologics,

so that participants can apply that knowledge to their countries’

regulatory frameworks.

Who Should Attend

National regulators, biologics manufacturers and procurement

agents involved in biologics quality assessments; professionals

involved in dossier assessments with a focus on biologics;

consultants and individuals interested in the regulatory

procedures to assess the safety, efficacy and quality of biologics

Learning Objectives � Understand the principles of biologics regulation to

ensure the safety, efficacy and quality of biologics

� Understand the details of manufacturing validation, with particular emphasis on vaccines, biologicals and sterile products

� Understand the components of regulatory safety, quality and efficacy approvals—from both clinical and quality

perspectives

Course Topics�

Good clinical practices

Clinical trials

Aseptic sterilization

Manufacturing, GMP, validation, stability and specifications for biologics

A biologic product manufactured in a prokaryotic cell (E. coli, Insulin)

A biologic manufactured in a mammalian cell line (Erythropoeitin)

Evaluation of a monoclonal antibody (Mabs)

Manufacturing, GMP, validation, stability and specifications

for vaccines

For more information, please visit usp.org/ghana.

Biologics

Next CePAT Course

To apply and be considered a candidate, contact [email protected] or visit usp.org/cepat.

Fees may apply. A welcome dinner will be provided. Group photos will be taken during the course.

Duration:

Location:

Format:

Date: